首页 | 本学科首页   官方微博 | 高级检索  
     

帕罗西汀治疗阿尔茨海默病的抑郁对照研究
引用本文:任清涛,刁艳云,耿国绪. 帕罗西汀治疗阿尔茨海默病的抑郁对照研究[J]. 临床精神医学杂志, 2004, 14(2): 90-91
作者姓名:任清涛  刁艳云  耿国绪
作者单位:1. 255100,山东淄博市第五人民医院
2. 山东淄博市沂源县土门医院
摘    要:目的:比较帕罗西汀与氯米帕明在阿尔茨海默病(AD)抑郁症状治疗中的疗效和不良反应。方法:帕罗西汀组51例,氯米帕明组44例,均诊断为AD,汉密顿抑郁量表(HAMD,17项)≥18分。比较两组患者治疗后的HAMD减分率,采用副反应量表(TESS)评定不良反应。结果:帕罗西汀组与氯米帕明组总体疗效相当,但帕罗西汀组起效较快,不良反应发生率低。结论:帕罗西汀在AD抑郁症状治疗中具有一定优势,值得临床推广应用。

关 键 词:帕罗西汀 氯米帕明 阿尔茨海默病 抑郁
文章编号:1005-3220(2004)02-0090-02
修稿时间:2003-06-19

A comparative study between paroxetine and clomipramine in the treatment of depression in Alzheimer disease
REN Qing-tao,DIAO Yan-yun,GENG Guo-xu. A comparative study between paroxetine and clomipramine in the treatment of depression in Alzheimer disease[J]. Journal of Clinical Psychological Medicine, 2004, 14(2): 90-91
Authors:REN Qing-tao  DIAO Yan-yun  GENG Guo-xu
Affiliation:REN Qing-tao,DIAO Yan-yun,GENG Guo-xu.The fifth People's Hospital of Zibo,Shandong 255100
Abstract:Objective:To compare the efficacy and security of paroxetine and clomipramine in the treatment of depression in Alzheimer disease(AD). Method:Ninty-nine patients with depression in AD were divided into treating group with paraxetine( n =51) and controlled group with clomipramine( n =44).Clinical progress was examined with HAMD-17 and TESS. Results:The overall effective rates of paroxetine group and clomipramine group were 98.0% and 95.5% respectively. No remarkable differences in the efficacy was found between two groups.But paroxetine had fewer adverse events and took effects more quickly. Conclusion:In the tratment of depression in Alzheimer disease,Paroxetine is an efficacious drug,with mild side effects.
Keywords:Paroxetine  Clomipramine  Alzheimer disease  Depression
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号